During an episode of the Joe Rogan Experience with comedian Whitney Cummings, host Joe Rogan addressed concerns about government restrictions on beneficial health items, specifically peptides.
The discussion emerged organically during a conversation that touched on healthcare fraud, government spending, and access to treatments. Rogan expressed frustration with regulatory efforts that he believes prioritize pharmaceutical profits over public health.
“They’re trying to keep like certain peptides from becoming legal,” Rogan stated during the podcast. He characterized these regulatory efforts as “silly” and argued that restricting access to beneficial stuff serves corporate interests rather than the public good.
Rogan elaborated on his position, saying the restrictions are problematic because “it’s all good for people. I know you’re not going to make money off of it. Doesn’t mean it’s not good for the overall human race.”
He went further, arguing that the ability to block beneficial products represents a systemic problem: “You shouldn’t be able to stop products that are super beneficial just because you can’t profit off of them. That means you have a captive industry. That’s not good for anybody. It’s not good for you that you’re allowed to do that. Shouldn’t be allowed to do that. It’s not good for anybody else.”
The podcast host specifically noted that “Peptides are really beneficial to people,” while acknowledging that certain peptides like GLP-1 inhibitors (including medications such as Ozempic and Wegovy) remain available because companies profit substantially from them. He said, “The ones that like GLP-1 inhibitors, do you know the numbers of people that are on those now? It’s kooki. It’s like more than 10 million in this country.”
Rogan contrasted the availability of these expensive prescription peptides with restrictions on other potentially beneficial items, suggesting an inconsistency in regulatory approach based on profitability rather than efficacy or safety.
